OrthoPediatrics Corp. (KIDS)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, OrthoPediatrics Corp. currently loses $10.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 27
in 47 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About OrthoPediatrics Corp.
OrthoPediatrics Corp. develops and sells pediatric orthopedic medical devices, trading on the NASDAQ as KIDS, with $236.3 million in revenue for FY2025. The company focuses on specialized implants and devices designed for children with orthopedic conditions, spanning trauma, deformity correction, spine, and sports medicine applications.
Today's Snapshot
KIDS opened 1% higher at 21.89, while its sector was flat.
Trading Volume
Above 10d avg 206.7K
315K
vs S&P 500 Today
Outperforming Market
+2.59%
Updated: September 10, 2026 at 14:33 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$19.40 - $22.98Sell
- RSI (14)39.75Neutral
- Stochastic %K (14, 3, 3)8.58Buy
- MACD Level (12, 26)-0.08Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.